TEMPOCONVISION S.A.S: public contracts won without a rival in Colombia: 2 uncontested awards; 13% of its awards; 2 without a competition; 0 single bid.
Assay record ASY-CO-183IJBG0D0 · Cite as: Assay Systems, “TEMPOCONVISION S.A.S: public contracts won without a rival in Colombia”, https://assay-systems.com/register/co/uncontested/s/tempoconvision-s-a-s/
TEMPOCONVISION S.A.S won 2 of its 15 public contract awards in Colombia without a rival from 2023-08-29 to 2024-01-31: 2 without a competition and 0 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Corporación Centro Internacional de Entrenamiento e Investigaciones Medicas CIDEIM with 2.
An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.
Corporación Centro Internacional de Entrenamiento e Investigaciones Medicas CIDEIM gave TEMPOCONVISION S.A.S 2 awards: 2 without a competition, 0 after a competition with a single bid. First 2023-08-29, latest 2024-01-31.
| Date | Buyer | How | Stated reason |
|---|---|---|---|
| 2024-01-31 | Corporación Centro Internacional de Entrenamiento e Investigaciones Medicas CIDEIM CO1.PCCNTR.5838932 | No competition Contratación directa | Urgencia manifiesta |
| 2023-08-29 | Corporación Centro Internacional de Entrenamiento e Investigaciones Medicas CIDEIM CO1.PCCNTR.5334892 | No competition Contratación directa | Urgencia manifiesta |
Every uncontested award in Colombia · All countries · TEMPOCONVISION S.A.S in the register
Source: SECOP II, Colombia Compra Eficiente open data (datos.gov.co). Awards are matched to their buyer and supplier as published. Values in these notices often state a framework ceiling rather than a contract amount, so awards are counted, not summed. Updated 17 October 2026.